GALLBLADDER CARCINOMA
Clinical trials for GALLBLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GALLBLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for GALLBLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy duo takes on rare tumors in nationwide trial
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…
Matched conditions: GALLBLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:35 UTC
-
Could a targeted drug boost chemo for biliary cancer?
Disease control OngoingThis study tests whether adding the targeted drug selumetinib to standard chemotherapy (cisplatin and gemcitabine) helps shrink tumors or slow cancer growth in people with advanced biliary tract or gallbladder cancer. About 57 adults who have not had prior treatment will receive …
Matched conditions: GALLBLADDER CARCINOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug combo aims to fight hard-to-treat stomach and bowel cancers
Disease control OngoingThis study tests whether adding the drug tucatinib to standard treatments (like trastuzumab and chemotherapy) is safe for people with HER2-positive cancers of the digestive system. About 40 adults with advanced cancer of the colon, stomach, esophagus, or gallbladder will receive …
Matched conditions: GALLBLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 22, 2026 13:50 UTC